Lysozyme amyloid: evidence for the W64R variant by proteomics in the absence of the wild type protein

Amyloid. 2020 Sep;27(3):206-207. doi: 10.1080/13506129.2020.1720637. Epub 2020 Feb 18.

Authors

Affiliations

¹ Wolfson Drug Discovery Unit and National Amyloidosis Centre, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK.
² Department of Molecular Medicine, Institute of Biochemistry, University of Pavia, Pavia, Italy.

No abstract available

Publication types

Letter

MeSH terms

Amyloid / genetics*
Amyloid / metabolism
Amyloidogenic Proteins / genetics*
Amyloidosis / genetics*
Amyloidosis / pathology
Humans
Muramidase / genetics
Muramidase / metabolism
Proteomics*

Substances

Amyloid
Amyloidogenic Proteins
Muramidase

Grants and funding

MR/R016984/1/MRC_/Medical Research Council/United Kingdom